An engineered CRISPR–Cas12i tool for efficient multiplexed genome editing
Nucleic Acids Research · 27.08.2025 · 53 (16)
DOI: 10.1093/nar/gkaf806 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 27.08.2025. Verfasst von Linli Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Animal Biotech Breeding, China Agricultural University, Beijing 100193, China. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Gene Editing, CRISPR-Associated Proteins, Endodeoxyribonucleases. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Great Projects of Agricultural Biotechnology Breeding in China, Unveiling List and Entrusting the Leader for Science and Technology, Chinese Universities Scientific Fund.
Abstract (Originalsprache)
Developing efficient and simplified tools for multiplexed genome editing remains challenging due to limitations in precursor CRISPR RNA (pre-crRNA) processing and reliance on additional RNA-based regulatory components. Cas12i.3, a small RNA-guided nuclease, reportedly lacks pre-crRNA processing ability, restricting its multiplexing capability. Here, we engineered Cas12i.3 by optimizing CRISPR RNA (crRNA) design, codon usage, and exonuclease fusion, generating initial optimized Cas12i (IOCas12i) system. Further rational design and amino acid mutations yielded the highly efficient enhanced optimized Cas12i (EOCas12i) systems, EOCas12i–Combo1 and EOCas12i–Combo2, exhibiting 2.5- to 22.8-fold and 3.0- to 60.0-fold editing efficiencies relative to wild-type Cas12i.3, comparable to Streptococcus pyogenes Cas9 (SpCas9) and Lachnospiraceae bacterium Cas12a (LbCas12a). Additionally, they exhibited high specificity and produced longer insertions and deletions (indels) that may facilitate gene knockout. Notably, both variants enabled efficient multiplexed editing of up to 30 targets using compact crRNA arrays. These advancements position EOCas12i–Combo1 and EOCas12i–Combo2 as promising platforms for multiplexed genome editing applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Animal Biotech Breeding, China Agricultural University, Beijing 100193, China.
- Beijing Key Laboratory of Animal Genetic Improvement, College of Animal Science and Technology, China Agricultural University, Beijing 100193, China.
- Key Laboratory of Animal Genetics, Breeding and Reproduction of the Ministry of Agriculture and Rural Affairs, College of Animal Science and Technology, China Agricultural University, Beijing 100193, China.
- Frontiers Science Center for Molecular Design Breeding (MOE), China Agricultural University, Beijing 100193, China.
ORCID-Profile: Jinsheng Lai, Hongbing Han
Förderung
- Great Projects of Agricultural Biotechnology Breeding in China
- Unveiling List and Entrusting the Leader for Science and Technology
- Chinese Universities Scientific Fund
- Pinduoduo-China Agricultural University Research Fund
Zitieren
APA
Wang, L., Wang, Y., Chen, J., Zhu, Y., Qin, H., Liu, J., Ai, Y., Lai, J., Lian, Z., & Han, H. (2025). An engineered CRISPR–Cas12i tool for efficient multiplexed genome editing. Nucleic Acids Research, 53(16). https://doi.org/10.1093/nar/gkaf806
Vancouver
Wang L, Wang Y, Chen J, Zhu Y, Qin H, Liu J, et al. An engineered CRISPR–Cas12i tool for efficient multiplexed genome editing. Nucleic Acids Research. 2025;53(16). doi:10.1093/nar/gkaf806
BibTeX
@article{Wang2025,
author = {Wang, Linli and Wang, Yanlu and Chen, Jian and Zhu, Yaning and Qin, Hao and Liu, Jie and Ai, Yue and Lai, Jinsheng and Lian, Zhengxing and Han, Hongbing},
title = {An engineered CRISPR–Cas12i tool for efficient multiplexed genome editing},
journal = {Nucleic Acids Research},
year = {2025},
volume = {53},
number = {16},
doi = {10.1093/nar/gkaf806}
}
EUVIMED